e-learning
resources
London 2016
Tuesday, 06.09.2016
Orphan diseases II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sirolimus induced diffuse alveolar hemorrhage: A case report
Baran Balcan (Istanbul, Turkey), Baran Balcan, Ergun Simsek, Aylin Ozsancak Ugurlu, Ebru Demiralay, Sevgi Sahin
Source:
International Congress 2016 – Orphan diseases II
Session:
Orphan diseases II
Session type:
Thematic Poster
Number:
3909
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Baran Balcan (Istanbul, Turkey), Baran Balcan, Ergun Simsek, Aylin Ozsancak Ugurlu, Ebru Demiralay, Sevgi Sahin. Sirolimus induced diffuse alveolar hemorrhage: A case report. Eur Respir J 2016; 48: Suppl. 60, 3909
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
Source: International Congress 2014 – ILDs 3
Year: 2014
Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
Immediate post-operative bronchoalveolar neutrophilia is associated with FEV
1
early after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Acute interstitial pneumonia: report of a series
Source: Eur Respir J 2003; 21: 187-191
Year: 2003
Clinical features and outcomes of patients with diffuse alveolar hemorrhage during antithrombotic therapy
Source: International Congress 2014 – ILDs 5
Year: 2014
Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage
Source: Eur Respir J 2009; 33: 1361-1366
Year: 2009
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Lung involvement in multiple myeloma - study case
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
Eosinophilic lung disease
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept